AI filing briefs · archive

8-K filings in November 2024, explained

513 material Form 8-K filings that 427 companies we cover made with the SEC in November 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

2 of 513 briefs match

newest first · times in ET

CENTCENTRAL GARDEN & PET CO Nov 25, 4:17 PM ET

Central Garden & Pet FY2024 GAAP EPS falls to $1.62; non-GAAP EPS rises to $2.13

Mixed earnings Written later 2.02

Central Garden & Pet reported fiscal 2024 net sales of $3.2 billion, down 3% from $3.3 billion, with GAAP diluted EPS of $1.62 versus $1.88 a year earlier and non-GAAP diluted EPS of $2.13 versus $2.07. The company expects fiscal 2025 non-GAAP EPS of $2.20 or better, while fourth-quarter results included a net loss of $34 million.

Fiscal 2024 net sales were $3.2 billion, down 3%; organic net sales fell 4%.
Fourth-quarter net sales were $669 million, down 11%, and the company posted a GAAP net loss of $34 million, or $0.51 per diluted share.
Fiscal 2025 non-GAAP EPS is expected to be $2.20 or better, according to the company's outlook.
Cash and cash equivalents were $754 million at September 28, 2024, compared with $489 million a year earlier.

Read the filing on SEC.gov ↗

BBWIBath & Body Works, Inc. Nov 25, 7:31 AM ET

Bath & Body Works Q3 sales rise 3% to $1.6 billion; full-year guidance raised

Mixed earnings Written later 2.02 7.01

Bath & Body Works reported third-quarter 2024 net sales of $1,610 million, up 3.0%, but diluted earnings per share fell to $0.49 from $0.52 a year earlier. The company raised its full-year 2024 earnings and net sales guidance, while its fourth-quarter outlook calls for net sales to decline 4.5% to 6.5% and earnings per share of $1.94 to $2.07 versus $2.55 a year earlier.

Q3 2024 net sales were $1,610 million, up 3.0% from $1,562 million; net income was $106 million versus $119 million
Q3 diluted EPS was $0.49 versus $0.52; adjusted EPS was $0.49 versus $0.48 after excluding a 2023 debt-extinguishment gain
Full-year 2024 GAAP EPS guidance raised to $3.46 to $3.59, including $400 million of planned share repurchases
Fourth-quarter 2024 net sales expected to decline 6.5% to 4.5%, with EPS of $1.94 to $2.07 versus $2.55 in Q4 2023

Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.